Sign in Subscribe
Leprosy

New Research on Leprosy Reveals Negative Impact on Quality of Life

Strategic Insights

— 1 min read

Research on leprosy conducted by the Department of Dermatology has revealed that the disease has a significant negative impact on the quality of life (QoL) of patients. The study, which evaluated the QoL of 60 leprosy patients in a tertiary care facility in Kerala, South India, found that 62% of patients experienced varying degrees of compromise in their quality of life. The mean Dermatology Life Quality Index (DLQI) score was 4.03 ± 4.83, indicating a lower impact of leprosy on QoL compared to previous studies. The researchers found a significant association between clinical factors, such as the site of the lesion, nerve palsy, trophic ulcer, and disability, and the QoL of patients. The study suggests that better healthcare systems and education can reduce the negative impact of leprosy on QoL.

Key Takeaways:

  • The study evaluated the QoL of 60 leprosy patients in a tertiary care facility in Kerala, South India, using the Dermatology Life Quality Index (DLQI) questionnaire.
  • 38.33% of patients had no adverse effects on their QoL due to leprosy, while the remaining patients experienced varying degrees of compromise.
  • The mean DLQI score was 4.03 ± 4.83, which is lower than previous studies and can be attributed to higher health standards and education levels.
  • Significant association was found between clinical factors like site of lesion, nerve palsy, trophic ulcer, and disability, and the QoL of patients.
  • The study suggests that better healthcare systems and education can reduce the negative impact of leprosy on QoL.
  • The QoL of individuals afflicted by leprosy is negatively impacted, with a lower DLQI score indicating a better quality of life.
  • The study highlights the importance of addressing the social and economic factors that contribute to the stigma and low QoL associated with leprosy.

Statistics:

  • 60 leprosy patients were evaluated in the study.
  • 38.33% of patients (23 individuals) had no adverse effects on their QoL due to leprosy.
  • The mean DLQI score was 4.03 ± 4.83.
  • 62% of patients experienced varying degrees of compromise in their QoL.
  • Significant association was found between clinical factors and the QoL of patients.

Sources:

  • A study of quality of life of leprosy patients in a tertiary care centre in Kerala. Journal of Krishna Institute of Medical Sciences University, 2025,14(2):91-97.
  • Department of Dermatology Researchers Provide New Insights into Leprosy (A study of quality of life of leprosy patients in a tertiary care centre in Kerala). World Disease Weekly. November 4, 2025; p 8.

Read more